Ali Satvat Net Worth & Insider Trades
Ali Satvat - Director, Eidos Therapeutics, Inc
What is Ali Satvat's Net Worth?
The current estimated net worth of Eidos Therapeutics, Inc's Director, Ali Satvat, is estimated to be about $614.36M . Ali Satvat owns about 24,575,501 units of Eidos Therapeutics, Inc common stock. In the last 2 years at Eidos Therapeutics, Inc, Ali Satvat has sold an estimated value of $3.6M worth.
What is Ali Satvat's Past Insider Trading?
Ali Satvat's largest purchase order was 1,103,848 units , worth over $28.62M on May 29, 2019. Ali Satvat's largest sale order was 211,762 units , worth over $3.6M on June 22, 2018. In total, Ali Satvat has made about 6 transactions over 2 years of their time at Eidos Therapeutics, Inc. Ali Satvat usually trades in May, July and June, with the busiest year in 2019. The most recent transaction was a purchase order of 882,353 units , worth over $26.38M on July 8, 2019.
Ali Satvat
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Ali Satvat's' Mailing Address?
- Mailing address is C/o Kohlberg Kravis Roberts & Co. 2800 Sand Hill Road, Suite 200 Menlo Park CA 94025 CA
What are Eidos Therapeutics, Inc's Past Insider Trades?
Eidos Therapeutics, Inc's most recent insider trade came on January 26, 2021 by Bridgebio Pharma Inc who bought 14,428,836 units worth $0 . In the last 3 years, insiders at Eidos Therapeutics, Inc have sold an estimated value of $34.74M and bought an estimated value of $352.62M worth of shares. Insider trading is most common in June, with the busiest year in 2019. The most active traders at the company are Jonathan Fox, See Remarks, Cameron Turtle, Chief Business Officer, and Christine Siu, CFO and Secretary .
Eidos Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||